Myocarditis in connective tissue diseases: an often-overlooked clinical manifestation.
Arthritis
Cardiac involvement
Connective tissue diseases
Myocarditis
Myositis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
13
06
2023
accepted:
08
08
2023
medline:
12
9
2023
pubmed:
17
8
2023
entrez:
16
8
2023
Statut:
ppublish
Résumé
To discuss what is currently known about myocarditis in the context of major connective tissue diseases, including Systemic lupus erythematosus, Rheumatoid Arthritis, Sjogren, Dermato-myositis and Polymyositis, Systemic Sclerosis, and Mixed connective tissue disease. Variability exists between studies regarding the incidence of myocarditis in connective tissue diseases, which is hypothesized to be the result of its subclinical course in most cases. Extensive gaps of knowledge exist in the field of pathophysiology. Although endomyocardial biopsy remains to be the gold standard for diagnosis, the advancement in non-invasive modalities such as cardiac MRI, echocardiography, and nuclear medicine has allowed for earlier and more frequent detection of myocarditis. A lack of treatment guidelines was found across the different connective tissue diseases. Most of the literature available revolved around myocarditis in the context of Systemic lupus erythematosus. Numerous recent studies were published that contributed to advancements in diagnosis and treatment however, there remains a lack of diagnostic and treatment guidelines.
Identifiants
pubmed: 37587233
doi: 10.1007/s00296-023-05428-w
pii: 10.1007/s00296-023-05428-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1983-1992Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Pepmueller PH (2006) Undifferentiated connective tissue disease, mixed connective tissue disease, and overlap syndromes in rheumatology. Mo Med 113:136–140
Stougiannos PN, Mytas DZ, Katsaros AA, Kakkavas AT, Androulakis AE, Kallikazaros IE, Chrissos DN (2009) Chest pain and ST-segment elevation in a patient with polymyositis: a case report. Cases J 2:84
pubmed: 19166609
pmcid: 2639563
doi: 10.1186/1757-1626-2-84
Rose NR (2016) Viral myocarditis. Curr Opin Rheumatol 2016(28):383–389
doi: 10.1097/BOR.0000000000000303
Rose NR, Neumann DA, Herskowitz A (1992) Coxsackievirus myocarditis. Adv Intern Med 37:411–429
pubmed: 1558005
Garg A, Shiau J, Guyatt G (1998) The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview. Ann Intern Med 129:317–322
pubmed: 9729186
doi: 10.7326/0003-4819-129-4-199808150-00009
Rose NR (2009) Myocarditis: infection versus autoimmunity. J Clin Immunol 29:730–737
pubmed: 19826933
doi: 10.1007/s10875-009-9339-z
Caforio ALP, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, Fu M, Heliö T, Heymans S, Jahns R et al (2013) Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 34:2636–2648, 2648a–2648d
pubmed: 23824828
doi: 10.1093/eurheartj/eht210
Villablanca P, Mohananey D, Meier G, Yap JE, Chouksey S, Abegunde AT (2015) Salmonella berta myocarditis: case report and systematic review of non-typhoid salmonella myocarditis. World J Cardiol 7:931–937
pubmed: 26730299
pmcid: 4691820
doi: 10.4330/wjc.v7.i12.931
Childs L, Gupta S (2012) Salmonella enteritidis induced myocarditis in a 16-year-old girl. BMJ Case Rep. https://doi.org/10.1136/bcr-2012-007628
doi: 10.1136/bcr-2012-007628
pubmed: 23188875
pmcid: 4545010
Van Diem L, Arnold K (1974) Typhoid fever with myocarditis. Am J Trop Med Hyg 23:218–221
doi: 10.4269/ajtmh.1974.23.218
Hidron A, Vogenthaler N, Santos-Preciado JI, Rodriguez-Morales AJ, Franco-Paredes C, Rassi AJ (2010) Cardiac involvement with parasitic infections. Clin Microbiol Rev 23:324–349
pubmed: 20375355
pmcid: 2863361
doi: 10.1128/CMR.00054-09
Pandey S, Rajasurya V (2023) Nonviral myocarditis. StatPearls Publishing, Treasure Island
Mavrogeni SI, Kitas GD, Dimitroulas T, Sfikakis PP, Seo P, Gabriel S, Patel AR, Gargani L, Bombardieri S, Matucci-Cerinic M et al (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135–148
pubmed: 27179903
doi: 10.1016/j.ijcard.2016.04.158
Podlesnikar T, Lapinskas T (2019) Cardiac involvement in connective tissue disorders: terra incognita. JACC Case Rep 1:243–245
pubmed: 34316797
pmcid: 8301536
doi: 10.1016/j.jaccas.2019.07.009
Ozierański K, Tymińska A, Kobylecka M, Caforio ALP, Šobić-Šaranović D, Ristić AD, Maksimović R, Seferović PM, Marcolongo R, Królicki L et al (2021) Positron emission tomography in clinically suspected myocarditis—STREAM study design. Int J Cardiol 332:113–118
pubmed: 33657398
doi: 10.1016/j.ijcard.2021.02.068
Justiz Vaillant AA, Goyal A, Varacallo M (2022) Systemic lupus erythematosus. StatPearls Publishing, Treasure Island
Jain D, Halushka MK (2009) Cardiac pathology of systemic lupus erythematosus. J Clin Pathol 62:584–592
pubmed: 19561227
doi: 10.1136/jcp.2009.064311
Badui E, Garcia-Rubi D, Robles E, Jimenez J, Juan L, Deleze M, Diaz A, Mintz G (1985) Cardiovascular manifestations in systemic lupus erythematosus. prospective study of 100 patients. Angiology 36:431–441
pubmed: 4025948
doi: 10.1177/000331978503600705
Tincani A, Rebaioli CB, Taglietti M, Shoenfeld Y (2006) Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus. Rheumatology (Oxford) 45:iv8–iv13
pubmed: 16980725
doi: 10.1093/rheumatology/kel308
Cheng C-Y, Baritussio A, Giordani AS, Iliceto S, Marcolongo R, Caforio ALP (2022) Myocarditis in systemic immune-mediated diseases: prevalence, characteristics and prognosis. A systematic review. Autoimmun Rev 21:103037
pubmed: 34995763
doi: 10.1016/j.autrev.2022.103037
Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH (1954) Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 33:291–437
pubmed: 13223169
doi: 10.1097/00005792-195412000-00001
Estes D, Christian CL (1971) The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore) 50:85–95
pubmed: 4109481
doi: 10.1097/00005792-197103000-00001
Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT (2021) Update οn the diagnosis and management of systemic lupus erythematosus. Ann Rheum Dis 80:14–25
pubmed: 33051219
doi: 10.1136/annrheumdis-2020-218272
Winau L, HinojarBaydes R, Braner A, Drott U, Burkhardt H, Sangle S, D’Cruz DP, Carr-White G, Marber M, Schnoes K et al (2018) High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus. Ann Rheum Dis 77:1590–1598
pubmed: 30077990
doi: 10.1136/annrheumdis-2018-213661
Burkard T, Trendelenburg M, Daikeler T, Hess C, Bremerich J, Haaf P, Buser P, Zellweger MJ (2018) The heart in systemic lupus erythematosus—a comprehensive approach by cardiovascular magnetic resonance tomography. PLoS One 13:e0202105
pubmed: 30273933
pmcid: 6167090
doi: 10.1371/journal.pone.0202105
Bulkley BH, Roberts WC (1975) The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med 58:243–264
pubmed: 1115070
doi: 10.1016/0002-9343(75)90575-6
Bidani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69:849–858
pubmed: 7004181
doi: 10.1016/S0002-9343(80)80010-6
Das SK, Cassidy JT (1975) Antiheart antibodies in patients with systemic lupus erythematosus. Am J Med Sci 265:275–280
doi: 10.1097/00000441-197304000-00002
Lash AD, Wittman AL, Quismorio FPJ (1986) Myocarditis in mixed connective tissue disease: clinical and pathologic study of three cases and review of the literature. Semin Arthritis Rheum 15:288–296
pubmed: 2940685
doi: 10.1016/0049-0172(86)90024-7
Logar D, Kveder T, Rozman B, Dobovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49:627–629
pubmed: 2396870
pmcid: 1004179
doi: 10.1136/ard.49.8.627
Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB (2018) Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus 27:1296–1302
pubmed: 29642752
doi: 10.1177/0961203318770018
Thomas G, Cohen Aubart F, Chiche L, Haroche J, Hié M, Hervier B, Costedoat-Chalumeau N, Mazodier K, Ebbo M, Cluzel P et al (2017) Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol 44:24–32
pubmed: 28042125
doi: 10.3899/jrheum.160493
Du Toit R, Herbst PG, van Rensburg A, du Plessis LM, Reuter H, Doubell AF (2017) Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus 26:38–47
pubmed: 27225211
doi: 10.1177/0961203316651741
Zawadowski GM, Klarich KW, Moder KG, Edwards WD, Cooper LTJ (2012) A contemporary case series of lupus myocarditis. Lupus 21:1378–1384
pubmed: 22892209
doi: 10.1177/0961203312456752
Law WG, Thong BY, Lian TY, Kong KO, Chng HH (2005) Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus 14:827–831
pubmed: 16302678
doi: 10.1191/0961203305lu2228oa
Ansari A, Larson PH (1985) Heart disease in systemic lupus erythematosus: diagnosis and management. Texas Hear Inst J 12:9–21
Manautou L, Jerjes-Sanchez C, Meraz M, Perez-Garcia LF, Diaz-Cid A, de la Peña-Almaguer E, Avila C, Sanchez L (2014) Myopericarditis with predominantly right ventricular involvement with normal B-type natriuretic peptide and cardiac tamponade as the initial manifestation of systemic lupus erythematosus. Lupus 23:935–938
pubmed: 24704777
doi: 10.1177/0961203314530486
Zhang L, Zhu Y-L, Li M-T, Gao N, You X, Wu Q-J, Su J-M, Shen M, Zhao L-D, Liu J-J et al (2015) Lupus myocarditis: a case–control study from China. Chin Med J (Engl) 128:2588–2594
pubmed: 26415795
doi: 10.4103/0366-6999.166029
Chung J-W, Joe D-Y, Park H-J, Kim H-A, Park H-S, Suh C-H (2008) Clinical characteristics of lupus myocarditis in Korea. Rheumatol Int 28:275–280
pubmed: 17634899
doi: 10.1007/s00296-007-0414-6
Neto A, Torres S, Pissarra D, Vasconcelos G (2021) Myocardial rupture and systemic lupus erythematosus: a case report. Eur Heart J Case Rep 5:ytaa458
pubmed: 33554016
doi: 10.1093/ehjcr/ytaa458
Mavrogeni S, Dimitroulas T, Kitas GD (2012) Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev 12:305–312
pubmed: 22617620
doi: 10.1016/j.autrev.2012.05.005
Alchammas J, Al-Faham Z, Roumayah Y, Wong OCY (2016) The evaluation of lupus myocarditis with 13N-ammonia and 18F-FDG PET. J Nucl Med Technol 44:210–211
pubmed: 26769599
doi: 10.2967/jnmt.115.165639
Wijetunga M, Rockson S (2002) Myocarditis in systemic lupus erythematosus. Am J Med 113:419–423
pubmed: 12401537
doi: 10.1016/S0002-9343(02)01223-8
Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, Arad M, Böhm M, Charron P, Elliott PM, Eriksson U et al (2017) Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J 38:2649–2662
pubmed: 28655210
doi: 10.1093/eurheartj/ehx321
Borenstein DG, Fye WB, Arnett FC, Stevens MB (1978) The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med 89:619–624. https://doi.org/10.7326/0003-4819-89-5-619
doi: 10.7326/0003-4819-89-5-619
pubmed: 717930
Naarendorp M, Kerr LD, Khan AS, Ornstein MH (1999) Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol 26:2257–2260
pubmed: 10529151
Chan YK, Li EK, Tam LS, Chow LTC, Ng HK (2003) Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol 32:306–308
pubmed: 14690145
doi: 10.1080/03009740310003956
Micheloud D, Calderón M, Caparrros M, D’Cruz DP (2007) Intravenous immunoglobulin therapy in severe lupus myocarditis: good outcome in three patients. Ann Rheum Dis 66:986–987
pubmed: 17576788
pmcid: 1955109
doi: 10.1136/ard.2006.058784
Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238–240
pubmed: 11206350
doi: 10.1007/s100670050091
Gottenberg J-E, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M et al (2005) Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases. Ann Rheum Dis 64:913–920
pubmed: 15550531
doi: 10.1136/ard.2004.029694
Mohanty B, Sunder A (2020) Lupus myocarditis—a rare case. J Fam Med Prim Care 9:4441–4443
doi: 10.4103/jfmpc.jfmpc_716_20
Meier FMP, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, Allanore Y, Distler O, Riemekasten G, Valentini G et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research Group database. Ann Rheum Dis 71:1355–1360
pubmed: 22615460
doi: 10.1136/annrheumdis-2011-200742
Cutolo M, Sulli A, Pizzorni C, Paolino S, Smith V (2016) Systemic sclerosis: markers and targeted treatments. Acta Reumatol Port 41:18–25
pubmed: 27115104
Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F et al (2002) Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 81:139–153
pubmed: 11889413
doi: 10.1097/00005792-200203000-00004
Vanthuyne M, Smith V, De Langhe E, Van Praet J, Arat S, Depresseux G, Westhovens R, Blockmans D, Badot V, Cogan E et al (2012) The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile. J Rheumatol 39:2127–2133
pubmed: 22984273
doi: 10.3899/jrheum.120283
Tyndall AJ, Bannert B, Vonk M, Airò P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Müller-Ladner U, Distler O et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809–1815
pubmed: 20551155
doi: 10.1136/ard.2009.114264
Vandecasteele EH, De Pauw M, Brusselle G, Decuman S, Piette Y, De Keyser F, Smith V (2016) The heart and pulmonary arterial hypertension in systemic sclerosis. Acta Clin Belg 71:1–18
pubmed: 27075793
doi: 10.1080/17843286.2015.1108538
Janosik DL, Osborn TG, Moore TL, Shah DG, Kenney RG, Zuckner J (1989) Heart disease in systemic sclerosis. Semin Arthritis Rheum 19:191–200
pubmed: 2690346
doi: 10.1016/0049-0172(89)90032-2
Lambova SC (2014) Manifestations in systemic sclerosis. World J Cardiol 6:993–1005
pubmed: 25276300
pmcid: 4176808
doi: 10.4330/wjc.v6.i9.993
Allanore Y, Avouac J, Kahan A (2008) Systemic sclerosis: an update in 2008. Jt Bone Spine 75:650–655
doi: 10.1016/j.jbspin.2008.07.003
Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M (2005) Heart involvement and systemic sclerosis. Lupus 14:702–707
pubmed: 16218471
doi: 10.1191/0961203305lu2204oa
Pussadhamma B, Tipparot T, Chaosuwannakit N, Mahakkanukrauh A, Suwannaroj S, Nanagara R, Foocharoen C (2020) Clinical outcomes of myocarditis after moderate-dose steroid therapy in systemic sclerosis: a pilot study. Int J Rheumatol. https://doi.org/10.1155/2020/8884442
doi: 10.1155/2020/8884442
pubmed: 33414828
pmcid: 7769651
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA et al (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in Collaboration with the Hear. Eur J Heart Fail 14:803–869
pubmed: 22828712
doi: 10.1093/eurjhf/hfs105
Follansbee WP, Curtiss EI, Medsger TAJ, Steen VD, Uretsky BF, Owens GR, Rodnan GP (1984) Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 310:142–148
pubmed: 6690931
doi: 10.1056/NEJM198401193100302
Follansbee WP, Curtiss EI, Medsger TAJ, Owens GR, Steen VD, Rodnan GP (1984) Myocardial function and perfusion in the CREST syndrome variant of progressive systemic sclerosis. exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med 77:489–496
pubmed: 6475990
doi: 10.1016/0002-9343(84)90110-4
Deswal A, Follansbee WP (1996) Cardiac involvement in scleroderma. Rheum Dis Clin North Am 22:841–860
pubmed: 8923599
doi: 10.1016/S0889-857X(05)70304-5
Pieroni M, De Santis M, Zizzo G, Bosello S, Smaldone C, Campioni M, De Luca G, Laria A, Meduri A, Bellocci F et al (2014) Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 43:526–535
pubmed: 23932313
doi: 10.1016/j.semarthrit.2013.07.006
Siegel RJ, O’Connor B, Mena I, Criley JM (1984) Left ventricular function at rest and during Raynaud’s phenomenon in patients with scleroderma. Am Heart J 108:1469–1476
pubmed: 6507243
doi: 10.1016/0002-8703(84)90694-X
Allanore Y, Meune C, Vignaux O, Weber S, Legmann P, Kahan A (2006) Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and tissue-Doppler echography study. J Rheumatol 33:2464–2469
pubmed: 17080515
Jakubaszek M, Kwiatkowska B, Maślińska M (2015) Polymyositis and dermatomyositis as a risk of developing cancer. Reumatologia 53:101–105
pubmed: 27407235
pmcid: 4847280
doi: 10.5114/reum.2015.51510
Zhang L, Wang G, Ma L, Zu N (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35:686–691
pubmed: 22847365
Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 83:35–42
pubmed: 14747766
doi: 10.1097/01.md.0000109755.65914.5e
Schiopu E, Phillips K, MacDonald PM, Crofford LJ, Somers EC (2012) Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther 14:R22
pubmed: 22284862
pmcid: 3392815
doi: 10.1186/ar3704
Bazzani C, Cavazzana I, Ceribelli A, Vizzardi E, Dei Cas L, Franceschini F (2010) Cardiological features in idiopathic inflammatory myopathies. J Cardiovasc Med (Hagerstown) 11:906–911
pubmed: 20625308
doi: 10.2459/JCM.0b013e32833cdca8
Haupt HM, Hutchins GM (1982) The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 50:998–1006
pubmed: 7137049
doi: 10.1016/0002-9149(82)90408-8
Denbow CE, Lie JT, Tancredi RG, Bunch TW (1979) Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 22:1088–1092
pubmed: 486220
doi: 10.1002/art.1780221007
Lundberg IE (2006) The heart in dermatomyositis and polymyositis. Rheumatology (Oxford) 45:iv18–iv21
pubmed: 16980718
doi: 10.1093/rheumatology/kel311
Lie JT (1995) Cardiac manifestations in polymyositis/dermatomyositis: how to get to heart of the matter. J Rheumatol 22:809–811
pubmed: 8587065
Taylor AJ, Wortham DC, Burge JR, Rogan KM (1993) The heart in polymyositis: a prospective evaluation of 26 patients. Clin Cardiol 16:802–808
pubmed: 8269658
doi: 10.1002/clc.4960161110
Péter A, Balogh Á, Szilágyi S, Faludi R, Nagy-Vincze M, Édes I, Dankó K (2015) Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis. J Rheumatol 42:272–281
pubmed: 25433528
doi: 10.3899/jrheum.140626
Erlacher P, Lercher A, Falkensammer J, Nassonov EL, Samsonov MI, Shtutman VZ, Puschendorf B, Mair J (2001) Cardiac troponin and beta-type myosin heavy chain concentrations in patients with polymyositis or dermatomyositis. Clin Chim Acta 306:27–33
pubmed: 11282091
doi: 10.1016/S0009-8981(01)00392-8
Bodor GS, Porterfield D, Voss EM, Smith S, Apple FS (1995) Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue. Clin Chem 41:1710–1715
pubmed: 7497610
doi: 10.1093/clinchem/41.12.1710
Hengstman GJD, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BGM (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65:1635–1638
pubmed: 16679430
pmcid: 1798474
doi: 10.1136/ard.2006.052191
Brouwer R, Hengstman GJ, Vree Egberts W, Ehrfeld H, Bozic B, Ghirardello A, Grøndal G, Hietarinta M, Isenberg D, Kalden JR et al (2001) Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 60:116–123
pubmed: 11156543
pmcid: 1753477
doi: 10.1136/ard.60.2.116
Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, Miller FW (1991) A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 70:360–374
pubmed: 1659647
doi: 10.1097/00005792-199111000-00002
Okada Y, Takakuwa Y, Ooka S, Ogawa Y, Kawahata K, Kobayashi Y, Yamaguchi K, Akashi Y (2021) Usefulness of 123I-BMIPP and 201TlCl nuclide scintigraphy in evaluation of myocarditis in patients with polymyositis or dermatomyositis. Medicine (Baltimore) 100:e27173
pubmed: 34516513
doi: 10.1097/MD.0000000000027173
Shigematsu T, Okayama H, Hiasa G, Kazatani Y (2016) (18)F-Fluorodeoxyglucose positron emission tomography for the diagnosis of myocarditis associated with polymyositis. Circ J 81:121–122
pubmed: 27733736
doi: 10.1253/circj.CJ-16-0811
Ohata S, Shimada T, Shimizu H, Murakami Y, Matsuno Y (2002) Myocarditis associated with polymyositis diagnosed by gadolinium-DTPA enhanced magnetic resonance imaging. J Rheumatol 29:861–862
pubmed: 11950039
Allanore Y, Vignaux O, Arnaud L, Puéchal X, Pavy S, Duboc D, Legmann P, Kahan A (2006) Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 65:249–252
pubmed: 16410529
pmcid: 1798005
doi: 10.1136/ard.2005.038679
Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE (2007) Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Ann Rheum Dis 66:1276–1283
pubmed: 17277004
doi: 10.1136/ard.2006.058644
Cheston HJ, Akhoon C, Dutta Roy S, Reynolds P (2022) Managing myocarditis in a patient with newly diagnosed dermatomyositis. BMJ Case Rep 15:e246989
pubmed: 35256366
doi: 10.1136/bcr-2021-246989
Touma Z, Arayssi T, Kibbi L, Masri AF (2008) Successful treatment of cardiac involvement in dermatomyositis with rituximab. Jt Bone Spine 75:334–337
doi: 10.1016/j.jbspin.2007.05.011
Afzal A, Higgins RS, Philbin EF (1999) Heart transplant for dilated cardiomyopathy associated with polymyositis. Heart 82:e4
pubmed: 10490578
pmcid: 1760297
doi: 10.1136/hrt.82.4.e4
Ntusi NAB, Piechnik SK, Francis JM, Ferreira VM, Matthews PM, Robson MD, Wordsworth PB, Neubauer S, Karamitsos TD (2015) Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping. JACC Cardiovasc Imaging 8:526–536
pubmed: 25890584
doi: 10.1016/j.jcmg.2014.12.025
Sigal LH, Friedman HD (1989) Rheumatoid pancarditis in a patient with well controlled rheumatoid arthritis. J Rheumatol 16:368–373
pubmed: 2724254
Howlett JG, McKelvie RS, Arnold JMO, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H et al (2009) Canadian Cardiovascular Society consensus conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 25:85–105
pubmed: 19214293
pmcid: 2691911
doi: 10.1016/S0828-282X(09)70477-5
Amigues I, Tugcu A, Russo C, Giles JT, Morgenstein R, Zartoshti A, Schulze C, Flores R, Bokhari S, Bathon JM (2019) Myocardial inflammation, measured using 18-fluorodeoxyglucose positron emission tomography with computed tomography, is associated with disease activity in rheumatoid arthritis. Arthritis Rheumatol (Hoboken, N.J.) 71:496–506
doi: 10.1002/art.40771
Slack JD, Waller B (1986) Acute congestive heart failure due to the arteritis of rheumatoid arthritis: early diagnosis by endomyocardial biopsy: a case report. Angiology 37:477–482
pubmed: 3729074
doi: 10.1177/000331978603700609
Kwon HJ, Coté TR, Cuffe MS, Kramer JM, Braun MM (2003) Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med 138:807–811
pubmed: 12755552
doi: 10.7326/0003-4819-138-10-200305200-00008
Liang M, Bao L, Xiong N, Jin B, Ni H, Zhang J, Zou H, Luo X, Li J (2015) Cardiac arrhythmias as the initial manifestation of adult primary Sjögren’s syndrome: a case report and literature review. Int J Rheum Dis 18:800–806
pubmed: 26171561
doi: 10.1111/1756-185X.12616
Inoue H, Kinoshita K, Sugiyama M, Funauchi M, Hanagama M, Nata M (2008) Sudden death from ischaemic heart disease in a female patient with Sjögren syndrome: a case report. Med Sci Law 48:261–265
pubmed: 18754216
doi: 10.1258/rsmmsl.48.3.261
Levin MD, Zoet-Nugteren SK, Markusse HM (1999) Myocarditis and primary Sjögren’s syndrome. Lancet (London, England) 354:128–129
pubmed: 10408493
doi: 10.1016/S0140-6736(99)02251-5
Watanabe T, Takahashi Y, Hirabayashi K, Tomaru U, Machida M (2019) Acute fulminant myocarditis in a patient with primary Sjögren’s syndrome. Scand J Rheumatol 48:164–165
pubmed: 30516409
doi: 10.1080/03009742.2018.1514068
Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159
pubmed: 4621694
doi: 10.1016/0002-9343(72)90064-2
Alves MR, Isenberg DA (2020) “Mixed connective tissue disease”: a condition in search of an identity. Clin Exp Med 20:159–166
pubmed: 32130548
pmcid: 7181542
doi: 10.1007/s10238-020-00606-7
Cappelli S, Bellando Randone S, Martinović D et al (2012) ‘To be or not to be’, ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum 41:589–598
pubmed: 21959290
doi: 10.1016/j.semarthrit.2011.07.010
Ungprasert P, Wannarong T, Panichsillapakit T, Cheungpasitporn W, Thongprayoon C, Ahmed S, Raddatz DA (2014) Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol 171:326–330
pubmed: 24433611
doi: 10.1016/j.ijcard.2013.12.079
Alpert MA, Goldberg SH, Singsen BH et al (1983) Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation 68:1182–1193
pubmed: 6640871
doi: 10.1161/01.CIR.68.6.1182
Oetgen WJ, Mutter ML, Lawless OJ et al (1983) Cardiac abnormalities in mixed connective tissue disease. Chest 83:185–188
pubmed: 6822098
doi: 10.1378/chest.83.2.185
Leung WH, Wong KL, Lau CP et al (1990) Echocardiographic identification of mitral valvular abnormalities in patients with mixed connective tissue disease. J Rheumatol 17:485–488
pubmed: 2348428
Burdt MA, Hoffman RW, Deutscher SL et al (1999) Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 42:899–909
pubmed: 10323445
doi: 10.1002/1529-0131(199905)42:5<899::AID-ANR8>3.0.CO;2-L
Hajas A, Szodoray P, Nakken B et al (2013) Clinical course prognosis and causes of death in mixed connective tissue disease. J Rheumatol 40:1134–1142
pubmed: 23637328
doi: 10.3899/jrheum.121272
Rebollar-González V, Torre-Delgadillo A, Orea-Tejeda A et al (2001) Cardiac conduction disturbances in mixed connective tissue disease. Rev Investig Clin 53:330–334
Whitlow PL, Gilliam JN, Chubick A, Ziff M (1980) Myocarditis in mixed connective tissue disease. Association of myocarditis with antibody to nuclear ribonucleoprotein. Arthritis Rheum 23:808–815
pubmed: 7406932
doi: 10.1002/art.1780230706